Literature DB >> 22342722

Disease-causing mutations in the acidic motif of WNK4 impair the sensitivity of WNK4 kinase to calcium ions.

Tao Na1, Guojin Wu, Ji-Bin Peng.   

Abstract

WNK4 is a serine/threonine protein kinase that is involved in pseudohypoaldosteronism type II (PHAII), a Mendelian form disorder featuring hypertension and hyperkalemia. Most of the PHAII-causing mutations are clustered in an acidic motif rich in negatively charged residues. It is unclear, however, whether these mutations affect the kinase activity in any way. In this study, we isolated kinase domain of WNK4 produced by Escherichia coli, and demonstrated its ability to phosphorylate the oxidative stress-responsive kinase-1 (OSR1) and the thiazide-sensitive Na(+)-Cl(-) cotransporter (NCC) in vitro. Threonine 48 was identified as the WNK4 phosphorylation site at mouse NCC. The phospho-mimicking T48D mutant of mouse NCC increased its protein abundance and Na(+) uptake, and also enhanced the phosphorylation at the N-terminal region of NCC by OSR1. When the acidic motif was included in the WNK4 kinase construct, the kinase activity of WNK4 exhibited sensitivity to Ca(2+) ions with the highest activity at Ca(2+) concentration around 1 μM using kinase-inactive OSR1 as a substrate. All tested PHAII-causing mutations at the acidic motif exhibited impaired Ca(2+) sensitivity. Our results suggest that these PHAII-causing mutations disrupt a Ca(2+)-sensing mechanism around the acidic motif necessary for the regulation of WNK4 kinase activity by Ca(2+) ions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342722      PMCID: PMC3358818          DOI: 10.1016/j.bbrc.2012.02.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  WNK3 positively regulates epithelial calcium channels TRPV5 and TRPV6 via a kinase-dependent pathway.

Authors:  Wei Zhang; Tao Na; Ji-Bin Peng
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-03

2.  WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4.

Authors:  Yi Jiang; William B Ferguson; Ji-Bin Peng
Journal:  Am J Physiol Renal Physiol       Date:  2006-10-03

3.  The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.

Authors:  Alberto C Vitari; Maria Deak; Nick A Morrice; Dario R Alessi
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

4.  Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.

Authors:  Amir P Golbang; Georgina Cope; Abbas Hamad; Meena Murthy; Che-Hsiung Liu; Alan W Cuthbert; Kevin M O'shaughnessy
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-20

5.  Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule.

Authors:  Maria D Lalioti; Junhui Zhang; Heather M Volkman; Kristopher T Kahle; Kristin E Hoffmann; Hakan R Toka; Carol Nelson-Williams; David H Ellison; Richard Flavell; Carmen J Booth; Yin Lu; David S Geller; Richard P Lifton
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

6.  Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter.

Authors:  Kenneth B E Gagnon; Roger England; Eric Delpire
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

7.  Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.

Authors:  Sung-Sen Yang; Tetsuji Morimoto; Tatemitsu Rai; Motoko Chiga; Eisei Sohara; Mayuko Ohno; Keiko Uchida; Shih-Hua Lin; Tetsuo Moriguchi; Hiroshi Shibuya; Yoshiaki Kondo; Sei Sasaki; Shinichi Uchida
Journal:  Cell Metab       Date:  2007-05       Impact factor: 27.287

8.  Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1.

Authors:  Ciaran Richardson; Fatema H Rafiqi; Håkan K R Karlsson; Ntsane Moleleki; Alain Vandewalle; David G Campbell; Nick A Morrice; Dario R Alessi
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

9.  WNK4 diverts the thiazide-sensitive NaCl cotransporter to the lysosome and stimulates AP-3 interaction.

Authors:  Arohan R Subramanya; Jie Liu; David H Ellison; James B Wade; Paul A Welling
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

10.  Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.

Authors:  Pedro San-Cristobal; Diana Pacheco-Alvarez; Ciaran Richardson; Aaron M Ring; Norma Vazquez; Fatema H Rafiqi; Divya Chari; Kristopher T Kahle; Qiang Leng; Norma A Bobadilla; Steven C Hebert; Dario R Alessi; Richard P Lifton; Gerardo Gamba
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-24       Impact factor: 11.205

View more
  15 in total

1.  Unveiling the Distinct Mechanisms by which Disease-Causing Mutations in the Kelch Domain of KLHL3 Disrupt the Interaction with the Acidic Motif of WNK4 through Molecular Dynamics Simulation.

Authors:  Lingyun Wang; Chen Jiang; Ruiqi Cai; Xing-Zhen Chen; Ji-Bin Peng
Journal:  Biochemistry       Date:  2019-04-10       Impact factor: 3.162

Review 2.  Regulation of the renal Na+-Cl- cotransporter by phosphorylation and ubiquitylation.

Authors:  Gerardo Gamba
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

3.  WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.

Authors:  María Chávez-Canales; Chong Zhang; Christelle Soukaseum; Erika Moreno; Diana Pacheco-Alvarez; Emmanuelle Vidal-Petiot; María Castañeda-Bueno; Norma Vázquez; Lorena Rojas-Vega; Nicholas P Meermeier; Shaunessy Rogers; Xavier Jeunemaitre; Chao-Ling Yang; David H Ellison; Gerardo Gamba; Juliette Hadchouel
Journal:  Hypertension       Date:  2014-08-11       Impact factor: 10.190

Review 4.  Revisiting the NaCl cotransporter regulation by with-no-lysine kinases.

Authors:  Silvana Bazúa-Valenti; Gerardo Gamba
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-18       Impact factor: 4.249

5.  Disease-causing R1185C mutation of WNK4 disrupts a regulatory mechanism involving calmodulin binding and SGK1 phosphorylation sites.

Authors:  Tao Na; Guojin Wu; Wei Zhang; Wen-Ji Dong; Ji-Bin Peng
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-10

6.  A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.

Authors:  Jose Ponce-Coria; Nicolas Markadieu; Thomas M Austin; Lindsey Flammang; Kerri Rios; Paul A Welling; Eric Delpire
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

Review 7.  Electroneutral absorption of NaCl by the aldosterone-sensitive distal nephron: implication for normal electrolytes homeostasis and blood pressure regulation.

Authors:  Dominique Eladari; Régine Chambrey; Nicolas Picard; Juliette Hadchouel
Journal:  Cell Mol Life Sci       Date:  2014-02-21       Impact factor: 9.261

8.  Disease-causing mutations in KLHL3 impair its effect on WNK4 degradation.

Authors:  Guojin Wu; Ji-Bin Peng
Journal:  FEBS Lett       Date:  2013-05-09       Impact factor: 4.124

9.  Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.

Authors:  María Castañeda-Bueno; Luz Graciela Cervantes-Pérez; Norma Vázquez; Norma Uribe; Sheila Kantesaria; Luciana Morla; Norma A Bobadilla; Alain Doucet; Dario R Alessi; Gerardo Gamba
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-01       Impact factor: 11.205

10.  Phosphorylation of KLHL3 at serine 433 impairs its interaction with the acidic motif of WNK4: a molecular dynamics study.

Authors:  Lingyun Wang; Ji-Bin Peng
Journal:  Protein Sci       Date:  2016-10-26       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.